Literature DB >> 12404172

Cross-reactivity between immunodominant human T lymphotropic virus type I tax and neurons: implications for molecular mimicry.

Michael C Levin1, Sang Min Lee, Yvette Morcos, John Brady, John Stuart.   

Abstract

Human T lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is associated with immunoreactivity to HTLV-I tax. Antibodies isolated from patients with HAM/TSP and monoclonal antibodies (MAbs) to HTLV-I tax stained neurons. In neuronal extracts, HAM/TSP immunoglobulin G identified heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) as the autoantigen. Importantly, tax MAbs reacted with hnRNP A1. To identify the epitope recognized by the tax MAbs, the fine epitope specificity of the antibodies was determined using overlapping peptides. This analysis identified an epitope at the C-terminus (tax(346-353)), which overlaps a human immunodominant domain. Preincubation of this peptide with tax MAbs inhibited antibody binding to tax, hnRNP A1, and neurons. This indicates that a cross-reactive immune response between HTLV-I tax and neuronal hnRNP A1 is contained within the human immunodominant epitope of tax and suggests that molecular mimicry plays a role in the pathogenesis of HAM/TSP.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12404172     DOI: 10.1086/344734

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  Mouse models of human T lymphotropic virus type-1-associated adult T-cell leukemia/lymphoma.

Authors:  B Zimmerman; S Niewiesk; M D Lairmore
Journal:  Vet Pathol       Date:  2010-05-04       Impact factor: 2.221

2.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

Review 3.  Role of Exosomes in Human Retroviral Mediated Disorders.

Authors:  Monique Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  J Neuroimmune Pharmacol       Date:  2018-04-14       Impact factor: 4.147

Review 4.  Exosomes in Viral Disease.

Authors:  Monique R Anderson; Fatah Kashanchi; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  Antibody transfection into neurons as a tool to study disease pathogenesis.

Authors:  Joshua N Douglas; Lidia A Gardner; Sangmin Lee; Yoojin Shin; Chassidy J Groover; Michael C Levin
Journal:  J Vis Exp       Date:  2012-09-26       Impact factor: 1.355

6.  Cross-reactive antibodies to target proteins are dependent upon oligomannose glycosylated epitopes in HTLV-1 associated neurological disease.

Authors:  Sangmin Lee; Yoojin Shin; Daniel Clark; Eduardo Gotuzzo; Michael C Levin
Journal:  J Clin Immunol       Date:  2012-03-06       Impact factor: 8.317

7.  Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease.

Authors:  Sang Min Lee; Floyd D Dunnavant; Haeman Jang; Joseph Zunt; Michael C Levin
Journal:  Neurosci Lett       Date:  2006-04-05       Impact factor: 3.046

8.  Autoantibodies to Non-myelin Antigens as Contributors to the Pathogenesis of Multiple Sclerosis.

Authors:  Michael C Levin; Sangmin Lee; Lidia A Gardner; Yoojin Shin; Joshua N Douglas; Chelsea Cooper
Journal:  J Clin Cell Immunol       Date:  2013-06-30

9.  Acetylation of the human T-cell leukemia virus type 1 Tax oncoprotein by p300 promotes activation of the NF-kappaB pathway.

Authors:  Julie Lodewick; Isabelle Lamsoul; Angela Polania; Sylvie Lebrun; Arsène Burny; Lee Ratner; Françoise Bex
Journal:  Virology       Date:  2009-02-05       Impact factor: 3.616

10.  Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods.

Authors:  R Brad Jones; Fabio E Leal; Aaron M Hasenkrug; Aluisio C Segurado; Douglas F Nixon; Mario A Ostrowski; Esper G Kallas
Journal:  J Negat Results Biomed       Date:  2013-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.